List of Excipients in API CRINECERFONT
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing CRINECERFONT
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Neurocrine Biosciences Inc | CRENESSITY | crinecerfont | 70370-5025 | FERRIC OXIDE RED | 2031-12-13 |
| Neurocrine Biosciences Inc | CRENESSITY | crinecerfont | 70370-5025 | FERRIC OXIDE YELLOW | 2031-12-13 |
| Neurocrine Biosciences Inc | CRENESSITY | crinecerfont | 70370-5025 | GELATIN | 2031-12-13 |
| Neurocrine Biosciences Inc | CRENESSITY | crinecerfont | 70370-5025 | GLYCERIN | 2031-12-13 |
| Neurocrine Biosciences Inc | CRENESSITY | crinecerfont | 70370-5025 | LAUROYL PEG-32 GLYCERIDES | 2031-12-13 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for CRINECERFONT
Excipient focus: FERRIC OXIDE RED
CRINECERFONT drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Neurocrine Biosciences Inc | crinecerfont | 70370-5025 |
| >Company | >Ingredient | >NDC |
CRINECERFONT drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
CRINECERFONT drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Neurocrine Biosciences Inc | crinecerfont | 70370-5025 |
| >Company | >Ingredient | >NDC |
CRINECERFONT drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
CRINECERFONT drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Neurocrine Biosciences Inc | crinecerfont | 70370-5025 |
| >Company | >Ingredient | >NDC |
CRINECERFONT drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
CRINECERFONT drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Neurocrine Biosciences Inc | crinecerfont | 70370-5025 |
| >Company | >Ingredient | >NDC |
CRINECERFONT drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LAUROYL PEG-32 GLYCERIDES
CRINECERFONT drug variants containing LAUROYL PEG-32 GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Neurocrine Biosciences Inc | crinecerfont | 70370-5025 |
| >Company | >Ingredient | >NDC |
CRINECERFONT drug variants not containing LAUROYL PEG-32 GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
CRINECERFONT drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Neurocrine Biosciences Inc | crinecerfont | 70370-5025 |
| >Company | >Ingredient | >NDC |
CRINECERFONT drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL DICAPRYLATE/DICAPRATE
CRINECERFONT drug variants containing PROPYLENE GLYCOL DICAPRYLATE/DICAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Neurocrine Biosciences Inc | crinecerfont | 70370-5025 |
| >Company | >Ingredient | >NDC |
CRINECERFONT drug variants not containing PROPYLENE GLYCOL DICAPRYLATE/DICAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
CRINECERFONT drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Neurocrine Biosciences Inc | crinecerfont | 70370-5025 |
| >Company | >Ingredient | >NDC |
CRINECERFONT drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
CRINECERFONT drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Neurocrine Biosciences Inc | crinecerfont | 70370-5025 |
| >Company | >Ingredient | >NDC |
CRINECERFONT drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: VITAMIN E POLYETHYLENE GLYCOL SUCCINATE
CRINECERFONT drug variants containing VITAMIN E POLYETHYLENE GLYCOL SUCCINATE
| Company | Ingredient | NDC |
|---|---|---|
| Neurocrine Biosciences Inc | crinecerfont | 70370-5025 |
| >Company | >Ingredient | >NDC |
CRINECERFONT drug variants not containing VITAMIN E POLYETHYLENE GLYCOL SUCCINATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
CRINECERFONT drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Neurocrine Biosciences Inc | crinecerfont | 70370-5025 |
| >Company | >Ingredient | >NDC |
CRINECERFONT drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch